MedPath

Comparison of oral and injectable route of vitamin B12 therapy in children with Vitamin B12 deficiency anaemia.

Phase 3
Conditions
Health Condition 1: D519- Vitamin B12 deficiency anemia, unspecified
Registration Number
CTRI/2023/04/051249
Lead Sponsor
Government medical college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Children of age group - 6 months to 18 years

2) Anemia as defined by WHO.

6-59 months â?? less than 110 g/l at sea level

5-11 yearsâ?? less than 115 g/l at sea level

12-14 yearsâ?? less than 120 g/l at sea level

More than 15 yearsâ?? less than 130 g/l at sea level25

Corrected haemoglobin concentration according to sea level correction factor for altitude.

3) Serum vitamin B12 levels below 350 pg/ml OR Holotranscobalamin levels below 35 pmol/l 22,26 will be included in

Exclusion Criteria

1. Children who have already received Vitamin B12.

2. Children who are already taking micronutrient supplementation.

3. Children with iron deficiency anemia

(Iron deficiency will be defined by serum ferritin <12 micrograms/L in less than 5 years and <15 microgram/L for more than 5 years, in the absence of other conditions affecting serum ferritin level, particularly inflammation)

4. Children who have received blood transfusion within last 1month.12

5. Any critical illness with hemodynamic compromise or on life support measures.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath